LIFR and melanoma: Interestingly, Guo et al. have shown that LIF/LIFR pro-metastatic effects in melanoma pass through the activation of the canonical JAK/STAT pathway, which is known to be pro-oncogenic, and does not implicate the Hippo pathway.